Table 3.
Schematic representation of the antioxidant capacity of the hydrolysates ranked from highest to lowest capacity
| Lipid oxidation inhibition | Iron chelation | ABTS | DPPH | |
|---|---|---|---|---|
| Highest antioxidative capacity | Colonab | Livera | Lunga | Hearta |
![]() |
Livera | Colonb | Colona | Colonb |
| Appendixa | Pancreasb | Appendixab | Appendixb | |
| Lungac | Appendixb | Pancreasab | Pancreasc | |
| Pancreasac | Rectumc | Rectumab | Rectumd | |
| Heartc | Lungd | Liverab | Livere | |
| Lowest antioxidant activity | Rectumc | Hearte | Heartb | Lunge |
Hydrolysates with different letters in the same columns are significantly different at P < 0.05. ABTS, 2,2′-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid); DPPH, 2,2-Diphenyl-1-(2,4,6-trinitrophenyl) hydrazyl.
